Search
Enter keywords, a title or a report id number below.
Your Search for 'The Outlook for Pharmaceuticals Worldwide' returned 1202 results - Page 1 of 61
Sort by
Sorted by
Rank
Top-Bottom
-
Europe Pharmaceutical Market Analysis, 2010-2014
Venn Research Inc, Aug 2010 , Pages: 221graduate increase over the years up to 2014. The Europe pharmaceuticals market generated total revenues of $187,306.7 million in 2009, representing a compound annual growth rate (CAGR) of 4.1% for the ... -
Asia-Pacific Pharmaceutical Market Analysis, 2010-2014
Venn Research Inc, Aug 2010 , Pages: 135respective values of $23,796.9 million and $9,603.3 million in 2009. Cardiovascular sales proved the most lucrative for the Asia-Pacific pharmaceuticals market in 2009, generating total revenues of $23,518.8 ... -
World Pharmaceutical Market Analysis - A Digest Guide, 2010-2014
Venn Research Inc, Aug 2010 , Pages: 435years up to 2014. The world pharmaceuticals market generated total revenues of $644,204.4 million in 2009, representing a compound annual growth rate (CAGR) of 4.3% for the period spanning 2005-2009. In ... -
Workforce Reductions in Pharmaceuticals - Outsourcing, External Innovation and Collaboration Will Drive the Industry Forward
GBI Research, Jun 2012 , Pages: 54-going reality. In the light of this fact, this new report focuses on managing staff during the redundancy process and managing site closures. It also investigates future outlook for the industry and ... -
Brazil Pharmaceutical Market Analysis, 2010-2014
Venn Research Inc, Aug 2010 , Pages: 38stabilize at the level of 7.2% annually till 2014. The Brazil pharmaceuticals market generated total revenues of $12,011.3 million in 2009, representing a compound annual growth rate (CAGR) of 8.4% for the ... -
Licensing Opportunities: Neurology
Decision Resources, Inc, Apr 2010 , Pages: 35candidates with potential worldwide sales of more than $300 million in 2015; vaccines in development for Alzheimer’s disease. - Major neurology players: Analysis of the neurology interests of more than 15 ... -
South Africa Pharmaceutical Market Analysis, 2010-2014
Venn Research Inc, Aug 2010 , Pages: 48(CAGR) of 1% for the period spanning 2005-2009. Alimentary/metabolism sales proved the most lucrative for the South Africa pharmaceuticals market in 2009, generating total revenues of $259.3 million ... -
Dealmaking and Industry Outlook: Autoimmune and Inflammatory Diseases
Decision Resources, Inc, Jul 2009 , Pages: 43, biotech’s financial crisis. Industry outlook: Ten therapy area drivers; factors holding back this therapy area; annual growth rates for specific disease areas; three events that will invigorate the therapy ... -
Antivirals: Novel Targets, Technologies, and Dealmaking
Decision Resources, Inc, Feb 2010 , Pages: 32and Disease Select Novel Targets N Protein F and G Proteins Corporate Highlights Alnylam Pharmaceuticals BioCryst Pharmaceuticals Sangamo BioSciences Outlook for Antiviral Drug Discovery and ... -
State of the Pharmaceutical Industry, 2010 - Critical Role of Midsize Pharma
Decision Resources, Inc, Jan 2010 , Pages: 46. - Generic pharmaceutical companies: Major generics companies, relative size based on worldwide sales, Big Pharma’s new affi nity for generics, nature of the relationship between Big Pharma and generics ... -
Taiwan Pharmaceutical Market Analysis, 2010-2014
Venn Research Inc, Aug 2010 , Pages: 58$23,796.9 million and $66,889.3 million in 2009. Alimentary/metabolism sales proved the most lucrative for the Taiwan pharmaceuticals market in 2009, generating total revenues of $507.1 million, equivalent ... -
China Pharmaceutical Market Analysis, 2010-2014
Venn Research Inc, Aug 2010 , Pages: 58$66,889.3 million and $10,838.7 million in 2009. Alimentary/metabolism sales proved the most lucrative for the China pharmaceuticals market in 2009, generating total revenues of $2,426.7 million, equivalent ... -
India Pharmaceutical Market Analysis, 2010-2014
Venn Research Inc, Aug 2010 , Pages: 58decelerating growth over the years up to 2014. The India pharmaceuticals market generated total revenues of $10,838.7 million in 2009, representing a compound annual growth rate (CAGR) of 11.3% for the period ... -
France Pharmaceutical Market Analysis, 2010-2014
Venn Research Inc, Aug 2010 , Pages: 106. The France pharmaceuticals market generated total revenues of $37,306.2 million in 2009, representing a compound annual growth rate (CAGR) of 3.2% for the period spanning 2005-2009. In comparison, the ... -
Czech Republic Pharmaceutical Market Analysis, 2010-2014
Venn Research Inc, Aug 2010 , Pages: 108slightly in the years up to 2014. The Czech Republic pharmaceuticals market generated total revenues of $2,867.5 million in 2009, representing a compound annual growth rate (CAGR) of 10% for the period ... -
The Targeted Cancer Therapies Pipeline: A Strategic Review
Decision Resources, Inc, Dec 2009 , Pages: 34. The fruit of these programs could further revolutionize the field of oncology and advance the field of personalized medicine. The launch of novel, targeted therapies promises both to offer treatment for ... -
South Korea Pharmaceutical Market Analysis, 2010-2014
Venn Research Inc, Aug 2010 , Pages: 58$23,796.9 million and $66,889.3 million in 2009. Cardiovascular sales proved the most lucrative for the South Korea pharmaceuticals market in 2009, generating total revenues of $1,804.1 million, equivalent ... -
Canada Pharmaceutical Market Analysis, 2010-2014
Venn Research Inc, Aug 2010 , Pages: 48million and $10,559.8 million in 2009. Cardiovascular sales proved the most lucrative for the Canada pharmaceuticals market in 2009, generating total revenues of $7,372.9 million, equivalent to 31.8% of ... -
Pain Management Treatment Markets
TriMark Publications, Mar 2013 , Pages: 144, manufacturing or developing pain management treatment products in the U.S. and worldwide. Additionally, this review provides detailed tables, charts and figures with past and projected sales data for the U.S ... -
Glycerin - Global Strategic Business Report
Global Industry Analysts, Inc, Oct 2011 , Pages: 290Glycerin - Global Strategic Business Report This report analyzes the worldwide markets for Glycerin in Million Pounds by the following End-Use Applications: Pharmaceuticals & Personal Care, Food ...
All rights reserved. © Copyright 2013 Research and Markets WWW6
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
